...
首页> 外文期刊>Genetic testing and molecular biomarkers >Association of a Chromosome Locus 9p21.3 CDKN2B-AS1 Variant rs4977574 with Hypertension: The TAMRISK Study
【24h】

Association of a Chromosome Locus 9p21.3 CDKN2B-AS1 Variant rs4977574 with Hypertension: The TAMRISK Study

机译:协会的染色体位点9 . 3CDKN2B-AS1变体rs4977574高血压:TAMRISK研究

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: Chromosome locus 9p21.3 CDKN2B antisense RNA 1 (CDKN2B-AS1) has been found to contain multiple genetic markers for coronary artery disease (CAD) by genome-wide association studies (GWAS). Of these, the association of variants rs4977574, rs10757274, and rs2383206 with hypertension was studied in the Tampere adult population cardiovascular risk study (TAMRISK). Materials and Methods: A Finnish cohort of 336 subjects diagnosed with hypertension and 444 controls was analyzed. Samples were genotyped for the CDKN2B-AS1 polymorphisms using Kompetitive Allele Specific PCR (KASP) or TaqMan techniques. Results: Individuals with the minor genotype GG of rs4977574 had less hypertension compared to the other genotypes (p=0.048, OR 1.58, 95% CI 1.01-2.48). The variants rs2383206 and rs10757274 were not associated with hypertension. Conclusions: Our findings suggest that the GG genotype of the CDKN2B-AS1 gene variant rs4977574, which has been previously associated with an increased CAD risk, is also associated with a decreased susceptibility to the development of hypertension.
机译:目的:染色体位点9 . 3 CDKN2B反义RNA1 (CDKN2B-AS1)被发现包含多个遗传标记对冠状动脉疾病(CAD)通过全基因组关联研究(GWAS)。变体rs4977574协会,这些rs10757274, rs2383206高血压研究了在坦佩雷成年人心血管风险研究(TAMRISK)。和方法:336年芬兰的科目诊断出患有高血压和444控制分析。CDKN2B-AS1使用Kompetitive等位基因多态性特定PCR (KASP)或TaqMan技术。结果:患者小基因型GGrs4977574高血压相比减少了其他基因型(p = 0.048, 1.58, 95%可信区间1.01 - -2.48)。没有与高血压有关。结论:我们的研究结果表明,GGCDKN2B-AS1基因变异的基因型rs4977574,此前有关增加CAD风险,也是相关的降低易感性高血压的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号